Gainwell Technologies LLC

Gainwell Technologies LLC

Gainwell Technologies was established in 2020 when Molina Healthcare sold its Molina Medicaid Solutions division to a consortium led by Veritas Capital. The founding principal was not a single operator but a private equity strategy; Veritas Capital, a New York-based investment firm specializing in government technology, remains the majority owner. The wealth origin is Veritas Capital's institutional and limited partner capital, not a family fortune. Gainwell's strategy centers on technology modernization and business process outsourcing for state Medicaid programs. The firm offers claims processing, pharmacy benefit management, data analytics, and population health management. It has secured contracts with states including Texas, New York, and California, often winning long-term deals to replace legacy systems. A notable deployment was the 2023 agreement to modernize the Texas Medicaid management system, valued at over $100 million (per Texas Health and Human Services, 2023). Geographic focus is exclusively the United States, with operations in over 20 states. The company employs over 8,000 people, according to its public job postings and contract disclosures. It has no publicly listed additional offices beyond its headquarters location, which is undisclosed in available sources. An adjacent vehicle is Veritas Capital's fund structure, which has backed other government technology firms like Cotiviti and Alteryx. Recent activity: June 2025: Gainwell was awarded a five-year, $1.5 billion contract by the New York State Department of Health to upgrade its Medicaid enterprise system (per New York State contract registry, June 2025). Gainwell's structural differentiator is its exclusive focus on Medicaid technology and administration, a niche that most large IT services firms treat as a vertical rather than a core business. The firm operates as a pure-play health technology outsourcer, competing directly with state-run systems and a handful of specialized vendors. Its concentration in government contracts creates high revenue visibility but also regulatory dependency.